文献速递泌尿生殖妇产影像MR

MRI特征能否区分卵巢黏液性癌与黏液性交界性肿瘤?

Can MRI features differentiate ovarian mucinous carcinoma from mucinous borderline tumor?
PubMed 文献 · Eur J Radiol · 2020-09-12

本研究回顾性纳入63例经病理证实的卵巢黏液性肿瘤患者(11例黏液性癌,52例黏液性交界性肿瘤),比较术前增强MRI表现。黏液性癌的最大肿瘤直径、最大壁结节直径及壁结节ADC值均与交界性肿瘤有显著差异,且壁结节>5mm和异常腹水的出现率更高;T2低信号微囊肿仅见于交界性肿瘤。

要点

  • 壁结节>5mm和异常腹水在黏液性癌中更常见,提示恶性可能。
  • 黏液性癌的最大壁结节直径显著大于交界性肿瘤,ADC值显著更低。
  • T2低信号微囊肿仅见于部分黏液性交界性肿瘤,可能为特异性征象。

关键影像表现/征象

  • 最大肿瘤直径在黏液性癌为219.7 ± 80.8 mm,大于交界性肿瘤的177.4 ± 56.5 mm(p < 0.05)。
  • 最大壁结节直径在黏液性癌为41.7 ± 33.8 mm,大于交界性肿瘤的6.6 ± 8.9 mm(p < 0.01)。
  • 壁结节>5 mm在黏液性癌中占82%,高于交界性肿瘤的29%(p < 0.01)。
  • 异常腹水在黏液性癌中占45%,高于交界性肿瘤的12%(p < 0.05)。
  • 壁结节ADC值在黏液性癌为1.20 ± 0.25 × 10-3 mm2/s,低于交界性肿瘤的1.61 ± 0.35 × 10-3 mm2/s(p < 0.05)。

诊断标准与关键数值

  • 壁结节>5 mm在黏液性癌中占82%,在黏液性交界性肿瘤中占29%(p < 0.01)。
  • 异常腹水在黏液性癌中占45%,在黏液性交界性肿瘤中占12%(p < 0.05)。
  • 壁结节ADC值在黏液性癌为1.20 ± 0.25 × 10-3 mm2/s,在黏液性交界性肿瘤为1.61 ± 0.35 × 10-3 mm2/s(p < 0.05)。

临床应用与阅片要点

  • 壁结节>5 mm和异常腹水更常见于黏液性癌,阅片时需注意评估。
  • 黏液性癌的最大壁结节直径更大且ADC值更低,可辅助鉴别。
  • T2低信号微囊肿仅见于13%的黏液性交界性肿瘤,可能提示交界性肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Our purpose was to determine if MRI could be used to distinguish ovarian mucinous carcinoma (MC) from mucinous borderline tumor (MBT).

MATERIALS AND METHODS: This study included 63 consecutive patients with histopathologically proven ovarian mucinous neoplasms (11 MCs and 52 MBTs) who underwent preoperative contrast-enhanced MRI. MRI images were retrospectively reviewed and compared between the 2 pathologies.

RESULTS: The maximum tumor diameters (219.7 ± 80.8 mm vs. 177.4 ± 56.5 mm, p < 0.05) and maximum mural nodule (MN) diameters (41.7 ± 33.8 mm vs. 6.6 ± 8.9 mm, p < 0.01) were significantly larger in MCs than in MBTs. MNs larger than 5 mm (82 % vs. 29 %, p < 0.01) and abnormal ascites (45 % vs. 12 %, p < 0.05) were significantly more frequent in MCs than in MBTs. Apparent diffusion coefficient (ADC) values of MN were significantly lower in MCs than in MBTs (1.20 ± 0.25 × 10-3 mm2/s vs. 1.61 ± 0.35 × 10-3 mm2/s, p < 0.05). No significant difference was found in number of loculi, honeycomb sign, stained glass appearance, fluid-fluid level, thickened septa larger than 5 mm, peritoneal dissemination, or T2 hypointense microcysts between MCs and MBTs. T2 hypointense microcysts were observed only in 7 MBTs (13%).

CONCLUSION: MRI findings of these 2 pathologies overlapped considerably. Compared with MBTs, MCs exhibited larger tumor size, larger MN size, and lower ADC values of MN, and MCs more frequently had MNs larger than 5 mm and abnormal ascites. T2 hypointense microcysts might be a specific MRI finding in MBTs.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Kaga T, Kato H, Hatano Y, et al. Can MRI features differentiate ovarian mucinous carcinoma from mucinous borderline tumor? Eur J Radiol. 2020. PMID: 32961452. doi:10.1016/j.ejrad.2020.109281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。